![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Cadila Pharmaceuticals Limited Ankleshwar In, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Aripiprazole, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2016-308 - Rev 01
This Chemical Type CEP, issued on November 18, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2617 associated with this CEP further emphasizes